197 related articles for article (PubMed ID: 25109793)
1. Cardiovascular pharmacogenetics of antihypertensive and lipid- lowering therapies.
Vanichakarn P; Hwa J; Stitham J
Curr Mol Med; 2014; 14(7):849-79. PubMed ID: 25109793
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular pharmacogenetics of anti-thrombotic agents and non-steroidal anti-inflammatory drugs.
Stitham J; Vanichakarn P; Ying L; Hwa J
Curr Mol Med; 2014; 14(7):909-31. PubMed ID: 25109796
[TBL] [Abstract][Full Text] [Related]
3. Personalized vascular medicine: individualizing drug therapy.
Degoma EM; Rivera G; Lilly SM; Usman MH; Mohler ER
Vasc Med; 2011 Oct; 16(5):391-404. PubMed ID: 22003003
[TBL] [Abstract][Full Text] [Related]
4. Precision Cardiovascular Medicine: State of Genetic Testing.
Giudicessi JR; Kullo IJ; Ackerman MJ
Mayo Clin Proc; 2017 Apr; 92(4):642-662. PubMed ID: 28385198
[TBL] [Abstract][Full Text] [Related]
5. Using genetics to guide treatment and drug development in cardiovascular medicine: time to reveal the proof in the pudding.
Nicholls SJ
Cardiovasc Res; 2020 Feb; 116(2):e30-e32. PubMed ID: 31845983
[No Abstract] [Full Text] [Related]
6. Fibrate pharmacogenomics: expanding past the genome.
House JS; Motsinger-Reif AA
Pharmacogenomics; 2020 Mar; 21(4):293-306. PubMed ID: 32180510
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomics and management of cardiovascular disease.
Howe LA
Nurse Pract; 2009 Aug; 34(8):28-35; quiz 36. PubMed ID: 19638892
[No Abstract] [Full Text] [Related]
8. Current concepts and molecular mechanisms in pharmacogenetics of essential hypertension.
Rahman F; Muthaiah N; Kumaramanickavel G
Indian J Pharmacol; 2021; 53(4):301-309. PubMed ID: 34414909
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics of lipid diseases.
Ordovas JM
Hum Genomics; 2004 Jan; 1(2):111-25. PubMed ID: 15601539
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological treatment of hypertension and hyperlipidemia in Izhevsk, Russia.
Cybulsky M; Cook S; Kontsevaya AV; Vasiljev M; Leon DA
BMC Cardiovasc Disord; 2016 Jun; 16():122. PubMed ID: 27255373
[TBL] [Abstract][Full Text] [Related]
11. Recent developments and future directions for the use of pharmacogenomics in cardiovascular disease treatments.
Berinstein E; Levy A
Expert Opin Drug Metab Toxicol; 2017 Sep; 13(9):973-983. PubMed ID: 28792790
[TBL] [Abstract][Full Text] [Related]
12. Initiation and maintenance of cardiovascular medications following cardiovascular risk assessment in a large primary care cohort: PREDICT CVD-16.
Mehta S; Wells S; Grey C; Riddell T; Kerr A; Marshall R; Ameratunga S; Harrison J; Kenealy T; Bramley D; Chan WC; Thornley S; Sundborn G; Jackson R
Eur J Prev Cardiol; 2014 Feb; 21(2):192-202. PubMed ID: 23033546
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of obesity drug therapy.
Guzman AK; Ding M; Xie Y; Martin KA
Curr Mol Med; 2014; 14(7):891-908. PubMed ID: 25109792
[TBL] [Abstract][Full Text] [Related]
14. Genetics and pharmacogenetics in the diagnosis and therapy of cardiovascular diseases.
Krasi G; Precone V; Paolacci S; Stuppia L; Nodari S; Romeo F; Perrone M; Bushati V; Dautaj A; Bertelli M
Acta Biomed; 2019 Sep; 90(10-S):7-19. PubMed ID: 31577248
[TBL] [Abstract][Full Text] [Related]
15. Underutilisation of cardiovascular medications among at-risk individuals.
Lewis SJ; Robinson JG; Fox KM; Grandy S;
Int J Clin Pract; 2010 Apr; 64(5):604-10. PubMed ID: 19909379
[TBL] [Abstract][Full Text] [Related]
16. Systemic and specific effects of antihypertensive and lipid-lowering medication on plasma protein biomarkers for cardiovascular diseases.
Enroth S; Maturi V; Berggrund M; Enroth SB; Moustakas A; Johansson Å; Gyllensten U
Sci Rep; 2018 Apr; 8(1):5531. PubMed ID: 29615742
[TBL] [Abstract][Full Text] [Related]
17. The next 10 years in personalized medicine in cardiology.
Tantry US; Gurbel PA
Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):933-5. PubMed ID: 23984921
[No Abstract] [Full Text] [Related]
18. A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application?
Verschuren JJ; Trompet S; Wessels JA; Guchelaar HJ; de Maat MP; Simoons ML; Jukema JW
Eur Heart J; 2012 Jan; 33(2):165-75. PubMed ID: 21804109
[TBL] [Abstract][Full Text] [Related]
19. Genomewide association studies in cardiovascular disease--an update 2011.
Zeller T; Blankenberg S; Diemert P
Clin Chem; 2012 Jan; 58(1):92-103. PubMed ID: 22125304
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.
Zaiou M; El Amri H
Clin Genet; 2017 Mar; 91(3):355-370. PubMed ID: 27714756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
